000 01373 a2200361 4500
005 20250516072150.0
264 0 _c20130129
008 201301s 0 0 eng d
022 _a1463-5224
024 7 _a10.1111/j.1463-5224.2011.00985.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBosiack, Ann P
245 0 0 _aEfficacy and safety of suberoylanilide hydroxamic acid (Vorinostat) in the treatment of canine corneal fibrosis.
_h[electronic resource]
260 _bVeterinary ophthalmology
_cSep 2012
300 _a307-14 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCell Death
650 0 4 _aCells, Cultured
650 0 4 _aCorneal Diseases
_xdrug therapy
650 0 4 _aDogs
650 0 4 _aFibroblasts
_xdrug effects
650 0 4 _aHistone Deacetylase Inhibitors
_xpharmacology
650 0 4 _aHydroxamic Acids
_xpharmacology
650 0 4 _aMyofibroblasts
_xdrug effects
650 0 4 _aTransforming Growth Factor beta1
_xpharmacology
650 0 4 _aVorinostat
700 1 _aGiuliano, Elizabeth A
700 1 _aGupta, Rangan
700 1 _aMohan, Rajiv R
773 0 _tVeterinary ophthalmology
_gvol. 15
_gno. 5
_gp. 307-14
856 4 0 _uhttps://doi.org/10.1111/j.1463-5224.2011.00985.x
_zAvailable from publisher's website
999 _c21430647
_d21430647